Tysabri IV infusion 300mg, manufactured by Biogen Japan (YJ code: 1190402A1028, standard: 300mg 15mL 1 bottle), contains Natalizumab. This medication is a humanized monoclonal antibody used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
Tysabri IV infusion 300mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
